Data Published in Frontiers in Molecular Neuroscience Demonstrate That ZyVersa’s Inflammasome ASC Inhibitor, IC 100, Is Effective in Reducing Brain Inflammation in a Preclinical Model of Aging
Age-related chronic inflammation induced by activation of NLRP1 inflammasomes is implicated in development and progression of neurodegenerative diseases such as Alzheimer’s and Parkinson’s diseases IC 100 research was conducted at the University of Miami Miller School of Medicine by…
Comments Off on Data Published in Frontiers in Molecular Neuroscience Demonstrate That ZyVersa’s Inflammasome ASC Inhibitor, IC 100, Is Effective in Reducing Brain Inflammation in a Preclinical Model of Aging